Cogent Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $5,588 | $0 |
Gross Profit | -1,080 | -1,066 | 4,794 | -855 |
EBITDA | -63,307 | -61,338 | -57,434 | -59,580 |
EBIT | -64,387 | -62,404 | -58,228 | -60,435 |
Net Income | -58,950 | -58,348 | -54,365 | -55,382 |
Net Change In Cash | 0 | 0 | 5,588 | 0 |
Free Cash Flow | -42,849 | -52,599 | -44,385 | -38,092 |
Cash | 88,219 | 215,801 | 53,229 | 86,810 |
Basic Shares | 99,240 | 94,804 | 86,730 | 86,165 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $7,871 |
Gross Profit | -3,588 | -5,878 | -147 | 7,845 |
EBITDA | -205,860 | -141,961 | -75,404 | -89,692 |
EBIT | -208,130 | -147,839 | -75,551 | -90,412 |
Net Income | -192,410 | -132,643 | -71,806 | -66,451 |
Net Change In Cash | 0 | 0 | 0 | 7,871 |
Cost of Revenue | -79,798 | -22,506 | 204,766 | |
Free Cash Flow | -156,420 | -125,501 | -60,482 | -35,850 |
Cash | 53,229 | 139,886 | 219,684 | 242,190 |
Basic Shares | 79,657 | 58,739 | 38,730 | 11,081 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.59 |
2024-03-31 | -$0.62 |
2023-12-31 | -$0.63 |
2023-09-30 | -$0.64 |
